Zum Inhalt wechseln

MEDIEN

FAQS

Wer ist Almirall?
HÄUFIG GESTELLTE FRAGEN

faqs
MEDIENKONTAKTE

Cohn & Wolfe
Tel: +34 91 531 50 97
Contact: Adriana Ibargüen

Almirall Media Relations
Tel: +34 93 291 30 00
Contact: Corporate Communications

Kontakt

Für Medien-Anfragen klicken Sie bitte auf den unten aufgeführten Link.

Kontakt

Neuigkeiten

21-04-2017

Almirall Receives Positive CHMP Opinion for Dimethyl Fumarate for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis

Almirall, S.A., the global pharmaceutical company based in Barcelona, today announced that the Committee for Medicina ...

19-04-2017

Appointment of new President & General Manager of ThermiGen, an Almirall company

Almirall, S.A., the global pharmaceutical company based in Barcelona, announced today the appointment of Vladimir Pa ...

24-03-2017

Almirall and Sun Pharma Announce Regulatory Filing of Tildrakizumab in Europe

Barcelona, SPAIN and Mumbai, INDIA, March 24, 2017: Almirall S.L, (Spanish Stock Exchange ticker: ALM, "Almirall") an ...